bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.970
-0.060 (-2.96%)
At close: May 11, 2026, 4:00 PM EDT
1.970
0.00 (0.00%)
After-hours: May 11, 2026, 5:19 PM EDT

bioAffinity Technologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
95141413-
Market Cap Growth
-5.24%-62.54%2.63%2.98%--
Enterprise Value
7.23-0.3613.8712.112.250
Last Close Price
1.971.1827.3044.1048.00-
PE Ratio
--0.14-1.21-1.62-0.88-
PS Ratio
1.580.861.515.452792.02-
PB Ratio
2.490.735.452.841.21-
P/TBV Ratio
1.460.284.242.650.65-
P/FCF Ratio
--0.57-1.93-2.28-3.13-
P/OCF Ratio
--0.57-1.95-2.29-3.29-
EV/Sales Ratio
1.28-0.061.484.78468.06-
EV/EBITDA Ratio
-0.04-1.66-1.57-0.56-
EV/EBIT Ratio
-0.03-1.55-1.52-0.56-
EV/FCF Ratio
-0.04-1.89-2.00-0.52-
Debt / Equity Ratio
0.300.110.310.230.02-0.96
Debt / EBITDA Ratio
-0.12-0.11-0.18-0.20-0.06-5.16
Debt / FCF Ratio
-0.13-0.12-0.20-0.26-0.06-5.55
Net Debt / Equity Ratio
-0.47-0.730.15-0.26-1.01-0.63
Net Debt / EBITDA Ratio
0.160.53-0.050.162.79-4.54
Net Debt / FCF Ratio
0.160.56-0.050.212.60-4.88
Asset Turnover
0.600.711.270.250.000
Inventory Turnover
57.63104.17259.63144.930.17-
Quick Ratio
1.192.410.721.6210.030.10
Current Ratio
1.362.600.871.7710.500.11
Return on Equity (ROE)
-290.34%-301.83%-242.44%-99.84%2319.94%55.56%
Return on Assets (ROA)
-121.91%-120.65%-121.37%-77.95%-58.82%-275.95%
Return on Invested Capital (ROIC)
-575.06%-417.19%-268.21%-450.95%430.89%154.95%
Return on Capital Employed (ROCE)
-180.45%-184.46%-190.85%-93.71%1477.98%19.56%
Earnings Yield
-177.56%-733.90%-82.42%-61.90%-113.13%-
FCF Yield
--176.88%-51.82%-43.89%-32.00%-
Buyback Yield / Dilution
-492.83%-325.83%-38.61%-94.43%-67.83%-0.31%
Total Shareholder Return
-492.83%-325.83%-38.61%-94.43%-67.83%-0.31%
Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q